BIGHAT BIOSCIENCES
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from todayโs most challenging diseases.
BIGHAT BIOSCIENCES
Industry:
Artificial Intelligence (AI) Biotechnology Medical Therapeutics
Founded:
2019-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.bighatbio.com
Total Employee:
51+
Status:
Active
Contact:
650-489-1337
Email Addresses:
[email protected]โ
Total Funding:
99.3 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Google Maps Content Delivery Network Global Site Tag JsDelivr Google Analytics 4
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
PredxBio
PredxBio is a computational pathology company developing AI tools to analyze whole slide image pathology samples based on spatial analytics.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Veyetals
Veyetals is a mobile application that helps to measures stress levels and blood pressure using artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-03-28 | Frugi Biotechnology | Frugi Biotechnology acquired by BigHat Biosciences | N/A |
Investors List
Gaingels
Gaingels investment in Series B - BigHat Biosciences
8VC
8VC investment in Series B - BigHat Biosciences
Andreessen Horowitz
Andreessen Horowitz investment in Series B - BigHat Biosciences
Amgen Ventures
Amgen Ventures investment in Series B - BigHat Biosciences
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Series B - BigHat Biosciences
Quadrille Capital
Quadrille Capital investment in Series B - BigHat Biosciences
GRIDS Capital
GRIDS Capital investment in Series B - BigHat Biosciences
AME Cloud Ventures
AME Cloud Ventures investment in Series B - BigHat Biosciences
Section 32
Section 32 investment in Series B - BigHat Biosciences
Innovation Endeavors
Innovation Endeavors investment in Series A - BigHat Biosciences
Official Site Inspections
http://www.bighatbio.com Semrush global rank: 2.88 M Semrush visits lastest month: 5.69 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "BigHat Biosciences"
About - BigHat Bio
We are an interdisciplinary, STEM-focused team supported by experienced leaders, world-class advisors, and top-notch investors.See details»
BigHat Biosciences - Home
BigHat Biosciences is reimagining antibody discovery and engineering with an AI-first experimental platform that integrates a high-speed wet lab with machine learning to create โฆSee details»
BigHat Biosciences - Crunchbase Company Profile
BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.See details»
BigHat Biosciences - LinkedIn
BigHat Biosciences | 9,019 followers on LinkedIn. BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform | BigHatโs โฆSee details»
BigHat Biosciences 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for BigHat Biosciences. Use the PitchBook Platform to explore the full profile.See details»
BigHat Biosciences: Contact Details, Revenue, Funding, Employees โฆ
BigHat uses AI and machine learning to accelerate the design of advanced antibody therapeutics, enabling the development of safer, more effective treatments for complex diseases. Backed by โฆSee details»
BigHat Bio - Org Chart, Teams, Culture & Jobs | The Org
View BigHat Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
BigHat Biosciences (USA) Funding: $99.3M - Medical โฆ
Mar 11, 2025 USA | Funding: $99.3M (+) Website: https://www.bighatbio.com BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.See details»
BigHat Biosciences - LifeScienceHistory.com
BigHat Biosciences๏พ mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics.See details»
BigHat Biosciences CEO and Key Executive Team - Craft.co
BigHat Biosciences's CEO & Co-Founder is Mark DePristo. Other executives include Peyton Greenside, CSO & Co-Founder; Elizabeth Schwarzbach, Chief Business Officer and 5 others. โฆSee details»
BigHat Biosciences Raises $75 Million in Series B Funding to โฆ
Jul 20, 2022 BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, to...See details»
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its ...
In addition to these collaborations, BigHat has active therapeutic programs spanning multiple domains of human health, including inflammation, oncology, hematology, and infectious โฆSee details»
BigHat Biosciences CEO, Founder, Key Executive Team, Board of โฆ
Explore {BigHat Biosciences's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
BigHat Biosciences
Mar 4, 2025 When Mark and I co-founded BigHat Biosciences in 2019, we had a bold vision: combine machine learning and synthetic biology to revolutionize therapeutic antibody design. โฆSee details»
AI in Action E274: Mark DePristo, Founder & CEO at BigHat
Oct 25, 2021 Mark DePristo, Founder & CEO at BigHat Biosciences joins host JP Valentine on the AI in Action podcast to discuss the motivation for setting up BigHat Bio, the success โฆSee details»
BigHat keeps dry amid stormy market, signs deal with Merck & Co.
Nov 29, 2022 BigHat Biosciences has inked a long-term, multiproject deal with Merck & Co, the biotech's second Big Pharma pact.See details»
BigHat Biosciences
Eddie got his PhD in Philosophy from the University of Massachusetts Amherst while running software development for Boston area start-ups. He has tackled diverse problems from full โฆSee details»
BigHat Biosciences Announces Research Collaboration with Merck
Nov 29, 2022 Collaboration leverages BigHatโs AI-enabled platform to expedite protein engineering to design and develop novel therapeutic candidates SAN MATEO, Calif.-- โฆSee details»
BigHat Biosciences
Our new facility includes a large, modular state-of-the art laboratory and sleek office space with beautiful views of the bay and mountains. It offers superb amenities from a well-equipped โฆSee details»
Newsroom - BigHat Bio
BigHatโs Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle ForwardSee details»